TMEM43 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.6242562850266E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
<1E-12 |
Normal-vs-Stage2 |
2.017100E-04 |
Normal-vs-Stage3 |
9.211400E-04 |
Normal-vs-Stage4 |
1.434230E-02 |
Stage1-vs-Stage2 |
6.918200E-01 |
Stage1-vs-Stage3 |
7.073800E-01 |
Stage1-vs-Stage4 |
2.308200E-01 |
Stage2-vs-Stage3 |
9.707600E-01 |
Stage2-vs-Stage4 |
3.423800E-01 |
Stage3-vs-Stage4 |
3.318400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
8.87520057446523E-11 |
Normal-vs-Asian |
2.872000E-01 |
Caucasian-vs-AfricanAmerican |
5.018800E-01 |
Caucasian-vs-Asian |
1.493030E-01 |
AfricanAmerican-vs-Asian |
1.484570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
4.89519536017724E-12 |
Male-vs-Female |
9.339200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.88400000045164E-07 |
Normal-vs-Extreme_Weight |
2.32149965917472E-10 |
Normal-vs-Obese |
1.0592970944856E-11 |
Normal-vs-Extreme_Obese |
3.951600E-02 |
Normal_Weight-vs-Extreme_Weight |
6.302400E-02 |
Normal_Weight-vs-Obese |
1.736130E-02 |
Normal_Weight-vs-Extreme_Obese |
8.013600E-01 |
Extreme_Weight-vs-Obese |
6.809200E-01 |
Extreme_Weight-vs-Extreme_Obese |
5.178800E-01 |
Obese-vs-Extreme_Obese |
3.211600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.013700E-04 |
Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
Normal-vs-Age(61-80Yrs) |
2.66453525910038E-15 |
Normal-vs-Age(81-100Yrs) |
2.623200E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.603000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.516000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.628000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.654300E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.394400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.813800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
<1E-12 |
Normal-VS-Type2 PRCC |
5.218500E-04 |
Normal-VS-KIRP CIMP |
3.796500E-04 |
Normal-VS-Unclassified PRCC |
1.41050000002085E-06 |
Type1 PRCC-VS-Type2 PRCC |
1.92801330456405E-12 |
Type1 PRCC-VS-KIRP CIMP |
9.002200E-01 |
Type1 PRCC-VS-Unclassified PRCC |
1.574570E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.982170E-04 |
Type2 PRCC-VS-Unclassified PRCC |
1.880670E-03 |
KIRP CIMP-VS-Unclassified PRCC |
3.772200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.05560000005245E-06 |
Normal-vs-N1 |
2.792700E-04 |
Normal-vs-N2 |
1.303840E-01 |
N0-vs-N1 |
2.691600E-01 |
N0-vs-N2 |
7.643000E-01 |
N1-vs-N2 |
8.259000E-01 |
|
|